🌍September 2, 2026·Sep 2Research

Response to “Efficacy and Safety of Tegoprazan‐Amoxicillin Dual Therapy for <scp> <i>Helicobacter pylori</i> </scp> Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials”

Publisher

Crossref

Global

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Crossref
Region: Global
Scope: Research
Published: September 2, 2026
Language: EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on doi.org

Leave the platform to read the original full article on the publisher site.

Source: Crossref

Scope: Research

Open original article

Related coverage

More related coverage

Crossref/14h ago

Evaluating the Clinical Use of Cefoperazone/ Sulbactam and Post-discharge Antibiotics Practices in Infectious Diseases Patients

Crossref/14h ago

Polycystic Ovary Syndrome (PCOS) -Associated Infertility: Clinical Insights and Emerging Deep Learning Approaches for Early Detection and Prediction

Crossref/14h ago

Low-Dose Silodosin for Premature Ejaculation: A Clinical Evaluation

Crossref/14h ago

Sociodemographic and Clinical Characteristics of TuberculosisPositivity and Rifampicin Resistance among Presumptive Patients inSouthern Punjab, Pakistan: A Cross-Sectional Study